Atherosclerotic carotid artery occlusion

被引：20

作者：

William J. Powers

机构：

[1] Room 2218F,

[2] Washington University School of Medicine,undefined

[3] East Building Imaging Center,undefined

来源：

Current Treatment Options in Cardiovascular Medicine | 2003年 / 5卷 / 6期

关键词：

Clopidogrel; Acute Ischemic Stroke; Ticlopidine; Main Drug Interaction; Recurrent Stroke;

D O I：

10.1007/s11936-003-0039-3

中图分类号：

学科分类号：

摘要：

Patients with acute stroke caused by atherosclerotic carotid artery occlusion (ACAO) should receive intravenous tissue plasminogen activator if they meet eligibility criteria. Patients with acute stroke caused by ACAO who are not eligible for intravenous tissue plasminogen activator should receive aspirin. Heparin or heparin-like drugs do not improve outcome and should not be used. Therapy for prevention of recurrent stroke in patients with ACAO should consist of lifestyle modifications, risk factor intervention, and aspirin. Other antiplatelet drugs should be considered in patients with contraindication to aspirin. Warfarin is not indicated. Extracranial-intracranial bypass surgery provides no benefit over medical therapy in preventing recurrent stroke in a general population of patients with ACAO or in any subgroups selected by clinical or arteriographic criteria. Extracranial-intracranial bypass surgery in patients selected by hemodynamic criteria should only be performed as part of a randomized controlled clinical trial. Other surgical or endovascular procedures have no proven value in treating or preventing stroke caused by ACAO. Asymptomatic carotid occlusion has a benign prognosis, and requires no specific treatment other than lifestyle modification and risk factor intervention.

引用

页码：501 / 509

页数：8

共 86 条

[1]

Pessin MS(1977)Clinical and angiographic features of carotid transient ischemic attacks N Engl J Med 296 358-362

[2]

Duncan GW(1997)Pilot study of carotid surgery for acute stroke Br J Surg 84 990-992

[3]

Mohr JP(1991)Prognosis of symptomatic carotid occlusion: an overview Cerebrovasc Dis 1 245-256

[4]

Poskaner DC(1997)Symptomatic carotid artery occlusion: a reappraisal of hemodynamic factors Stroke 28 2084-2093

[5]

Mead GE(1998)Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion JAMA 280 1055-1060

[6]

Murray H(2000)Outcome in patients with symptomatic occlusion of the internal carotid artery Eur J Vasc Endovasc Surg 19 579-586

[7]

Farrell A(1999)Cerebral hemodynamic impairment: methods of measurement and association with stroke risk Neurology 53 251-259

[8]

Hankey GJ(2002)Use of cerebrovascular reactivity in patients with symptomatic major cerebral artery occlusion to predict 5-year outcome: comparison of xenon-133 and iodine-123-IMP single photon emission computed tomography J Cereb Blood Flow Metab 22 1142-1148

[9]

Warlow CP(1999)Significance of increased oxygen extraction fraction in 5-year prognosis of major cerebral arterial occlusive diseases J Nucl Med 40 1992-1998

[10]

Klijn CJM(2002)Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study Stroke 33 1857-1862

← 1 2 3 4 5 6 7 8 9 →